Alexander M. Castellino, PhD

Alexander Castellino is a freelance writer who has been writing in the oncology space for over 15 years. After graduating in the biological sciences, he decided that, for him, the pen was mightier than the bench. He started writing with Nature Biotechnology, contributing to their News in Brief. Alex writes across a wide variety of topics, and in oncology he works with the ASCO Daily News, Medscape Oncology, and Cancer Therapy Advisor. When he is not writing, Alex loves to read, cook, and travel.

Most Recent Articles by Alexander M. Castellino, PhD

The Changing Treatment Landscape for Advanced Renal Cell Carcinoma

The Changing Treatment Landscape for Advanced Renal Cell Carcinoma

By

Interferon or high-dose interleukin-2 were the only available options for the treatment of metastatic RCC until 2005.

Guideline Updates on Quality Palliative Care

Guideline Updates on Quality Palliative Care

By

A draft guideline from the National Consensus Project for Quality Palliative Care describes best practices for caring for individuals who are seriously ill.

Prognostic Model for Survival in Metastatic Prostate Cancer

Prognostic Model for Survival in Metastatic Prostate Cancer

By

Utilizing data from the PREVAIL dataset, researchers developed mathematical models that can provide prognostic information for men being treated with enzalutamide for chemotherapy-naïve metastatic castration-resistant prostate cancer.

The Immune Landscape in Metastatic Breast Cancer Is "More Inert"

The Immune Landscape in Metastatic Breast Cancer Is "More Inert"

By

Researchers compared the immune microenvironments of primary tumors with those at sites of metastases.

Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis

Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis

By

A matching-adjusted indirect comparison concluded that ponatinib offers better disease control compared with bosutinib in certain patients.

More Articles by Alexander M. Castellino, PhD

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs